Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Erasca, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +8 vs. Q2 2024
- Shares held
- 232.0M
- +39.1M (+20.3%) vs. Q2 2024
- Total value
- $633.4M
- +$178.0M (+39.1%) vs. Q2 2024
- New holders
- 26
- 54 more added
- Sold out
- 18
- 29 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $5.13B |
| Q1 2026 | 225 | $4.39B |
| Q4 2025 | 154 | $815.7M |
| Q3 2025 | 141 | $468.5M |
| Q2 2025 | 142 | $277.1M |
| Q1 2025 | 154 | $307.3M |
| Q4 2024 | 146 | $579.5M |
| Q3 2024 | 132 | $633.4M |
| Q2 2024 | 126 | $480.6M |
| Q1 2024 | 108 | $149.7M |
| Q4 2023 | 119 | $147.5M |
| Q3 2023 | 109 | $140.4M |
| Q2 2023 | 112 | $205.2M |
| Q1 2023 | 118 | $234.9M |
| Q4 2022 | 107 | $343.9M |
| Q3 2022 | 88 | $627.9M |
| Q2 2022 | 89 | $428.3M |
| Q1 2022 | 82 | $626.6M |
| Q4 2021 | 63 | $988.0M |
| Q3 2021 | 55 | $919.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Erasca, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 1,537,949 | $4.20M | 0.00% | +684,308+80.2% | Added |
| Charles Schwab Investment Management Inc | 1,723,630 | $4.71M | 0.00% | +390,209+29.3% | Added |
| Sofinnova Investments, Inc. | 1,842,668 | $5.03M | 0.42% | +143,140+8.4% | Added |
| Prosight Management, LP | 1,984,010 | $5.42M | 1.37% | −765,990−27.9% | Reduced |
| JPMorgan Chase & Co | 2,024,514 | $5.53M | 0.00% | −13,100−0.6% | Reduced |
| Soleus Capital Management, L.P. | 2,162,162 | $5.90M | 0.49% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 2,219,186 | $6.06M | 2.71% | −655,350−22.8% | Reduced |
| Millennium Management LLC | 2,410,550 | $6.58M | 0.01% | +1,595,777+195.9% | Added |
| Affinity Asset Advisors, LLC | 2,499,431 | $6.82M | 1.06% | 00.0% | Unchanged |
| AH Capital Management, L.L.C. | 2,862,500 | $7.81M | 0.69% | 00.0% | Unchanged |
| Marshall Wace, LLP | 3,027,727 | $8.27M | 0.01% | −644,648−17.6% | Reduced |
| Goldman Sachs Group Inc | 3,230,356 | $8.82M | 0.00% | +1,037,720+47.3% | Added |
| Janus Henderson Group PLC | 4,109,548 | $11.2M | 0.01% | −4,068,544−49.7% | Reduced |
| Woodline Partners LP | 4,138,849 | $11.3M | 0.10% | +4,813+0.1% | Added |
| Bank of America Corp | 4,220,671 | $11.5M | 0.00% | +2,498,961+145.1% | Added |
| Citadel Advisors LLC | 4,315,673 | $11.8M | 0.01% | +1,022,302+31.0% | Added |
| Geode Capital Management, LLC | 4,502,698 | $12.3M | 0.00% | +1,190,807+36.0% | Added |
| PFM Health Sciences, LP | 4,876,911 | $13.3M | 0.76% | +205,137+4.4% | Added |
| 5AM Venture Management, LLC | 5,405,404 | $14.8M | 3.05% | 00.0% | Unchanged |
| State Street Corp | 6,027,620 | $16.5M | 0.00% | +3,569,440+145.2% | Added |
| Vivo Capital, LLC | 6,756,756 | $18.4M | 1.53% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 6,946,488 | $19.0M | 4.27% | −870,438−11.1% | Reduced |
| Siren, L.L.C. | 8,857,179 | $24.2M | 1.21% | +8,857,179 | New |
| Paradigm Biocapital Advisors LP | 10,668,141 | $29.1M | 1.02% | +3,418,141+47.1% | Added |
| Logos Global Management LP | 10,900,000 | $29.8M | 3.33% | +5,000,000+84.7% | Added |
| ARCH Venture Management, LLC | 11,055,554 | $30.2M | 11.58% | 00.0% | Unchanged |
| Vanguard Group Inc | 13,288,740 | $36.3M | 0.00% | +2,936,994+28.4% | Added |
| Suvretta Capital Management, LLC | 13,768,039 | $37.6M | 1.35% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,356,680 | $41.9M | 0.00% | +15,356,680 | New |
| VR Adviser, LLC | 16,216,216 | $44.3M | 2.32% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 16,830,856 | $45.9M | 0.03% | +9,456,497+128.2% | Added |
| Frazier Life Sciences Management, L.P. | 19,391,687 | $52.9M | 2.12% | +3,175,471+19.6% | Added |
| Artal Group S.A. | 0 | $0 | 0.00% | −9,630,810−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −4,319,484−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −1,185,758−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −324,248−100.0% | Sold out |
| Regents of the University of California | 0 | $0 | 0.00% | −236,236−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −208,424−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −166,200−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −150,826−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −79,529−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −68,300−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −57,504−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −17,414−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −15,170−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −14,188−100.0% | Sold out |
| Sanders Morris Harris LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −3,100−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,161−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −1,868−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |